+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Oral Anticoagulant Therapy at Elderly Age: Heart Failure and Nonvalvular Atrial Fibrillation



Oral Anticoagulant Therapy at Elderly Age: Heart Failure and Nonvalvular Atrial Fibrillation



American Journal of Geriatric Cardiology 5(1): 78-83




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046875744

Download citation: RISBibTeXText

PMID: 11416372


Related references

Heart Failure and Mortality in Patients With Nonvalvular Atrial Fibrillation Started on Novel Oral Anticoagulant Therapy: A Single-Center Experience. Clinical and Applied Thrombosis/Hemostasis 23(5): 454-459, 2015

Very low-intensity anticoagulant therapy in elderly cardioembolic stroke patients with nonvalvular atrial fibrillation. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 31(9): 711-715, 1994

Direct oral anticoagulant use in nonvalvular atrial fibrillation with valvular heart disease: a systematic review. Clinical Cardiology 40(6): 407-412, 2016

Oral anticoagulant treatment in geriatric patients with nonvalvular atrial fibrillation in the era of direct oral anticoagulant agents. European Journal of Internal Medicine 25(5): E63-E65, 2015

Anticoagulation control in hospitalised patients with nonvalvular atrial fibrillation undergoing long-term oral anticoagulant therapy. Revista Clinica Espanola 218(5): 267-269, 2018

Comparison of claims vs patient-reported adherence measures and associated outcomes among patients with nonvalvular atrial fibrillation using oral anticoagulant therapy. Patient Preference and Adherence 12: 105-117, 2018

Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation. Thrombosis and Haemostasis 100(1): 16-17, 2008

Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation. Circulation. Cardiovascular Quality and Outcomes 8(2 Suppl 1): S12-S20, 2015

Are geriatric syndromes associated with reluctance to initiate oral anticoagulation therapy in elderly adults with nonvalvular atrial fibrillation?. Journal of the American Geriatrics Society 61(12): 2236-2237, 2014

Oral Anticoagulant Agents in Patients With Atrial Fibrillation and Heart Failure: Does Heart Failure Status Influence Efficacy and Safety?. Jacc. Heart Failure 4(11): 881-884, 2016

Selecting an oral anticoagulant for patients with nonvalvular atrial fibrillation. Journal of Thrombosis and Thrombolysis 39(1): 129-138, 2015

Oral anticoagulant discontinuation in patients with nonvalvular atrial fibrillation. American Journal of Managed Care 22(1): E1-E8, 2017

Use of oral anticoagulant therapy in patients with congestive heart failure and atrial fibrillation Analysis on 1,391 patients on the Italian Network Congestive Heart Failure. European Heart Journal 19(ABST SUPPL ): 298, 1998

How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillation. Annals of Hematology 95(3): 437-449, 2016

Physician's fear of anticoagulant therapy in nonvalvular atrial fibrillation. American Journal of the Medical Sciences 348(6): 513-521, 2015